be_ixf;ym_202411 d_22; ct_50

Latest Insights on TOI

abbvie stock Profit From AbbVie’s Struggles Today Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
Of the people, by the people, for the people … well, half of us, at least. Maybe smartphone voting will change that? Voting Gets Lazy; Cash-Craving Comcast; Broadcom Bites the Apple
by Joseph Hargett January 24, 2020 Great Stuff
Friday Four Play: The “Getting Lazy” Edition Lazy. The entire country is lazy. We have amazing freedoms in this country … freedoms that are the envy of the world: freedom of speech, freedom of the press, freedom of religion, the right to bear arms, et cetera. But the most important of all? The freedom (and […]
Biotech. All those big scary words that have no real-world meaning to investors, but the $775 billion market should pique your interest. Sometimes, It’s Lupus; Sage’s Depressing Results
by Joseph Hargett December 5, 2019 Great Stuff
The Right Prescription for Massive Returns Today, dear readers, we’re going to cover a topic I just know you all love and adore: biotechnology. I can hear the groans already … and I get it. All those big scary words that have no real meaning to you at all. It’s like they’re talking about some […]
2020 earnings season This Is THE Options Trading Strategy for Earnings Season in 2020 Companies announce their earnings four times a year. Investors speculate on how a stock will move based on earnings — but doing so is a bad habit. With this approach, though, you don’t make a move until after companies report earnings. Anthony Planas talks about this revolutionary strategy that will change how you make money. (3-minute read)
Investing for Value or Growth? Don’t Choose 1 … Get Both I encourage you to enjoy the best of both worlds. You can do that by buying this reasonably priced stock that’s growing too.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving the 238% gain after I bought your recommendation in Sept. 2019! This week (July 21, 2020) will be my 1 year anniversary with your amazing team … thanks for the life-changing work you all do! Between all your services, 14 triple-digit gains, the greatest at 358%!"

- Matt

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

Share This